DKP Critical Insights® Syndicated Reports
DKP has developed a series of syndicated reports to provide perspectives into the oncology and rare-disease environment. The reports are designed to help you inform short- and long-term strategies that will support market positioning of your portfolio, as well as ongoing patient access to care.
Clinical Drug Compendia Overview Guide
Click here for more information
- Understand the important influence of clinical drug compendia for oncology drug decision making with both payers and providers
- Identify specific compendium nuances and submission requirements, especially for new drugs (oral and IV)